Skip to main content

Table 1 Baseline characteristics of the CENTRAL participants across sex-specific tertiles of mAge deviation

From: Lifestyle weight-loss intervention may attenuate methylation aging: the CENTRAL MRI randomized controlled trial

 

Entire

n = 120

Low

tertile

n = 40

Intermediate tertile

n = 41

High tertile

n = 39

p between tertilesa

p between extreme tertilesb

Age, years

48.6 ± 9.3

45.1 ± 10.2

50.7 ± 9.0

47.3 ± 8.4

0.19

0.92

mAge, years

60.3 ± 7.5

56.5 ± 7.5

62.2 ± 6.9

62.3 ± 6.8

2.6 × 10–4

0.001

Weight, kg

90.3 ± 11.4

88.3 ± 9.5

89.3 ± 12.9

92.9 ± 11.5

0.17

0.06

BMI, kg/m2

30.2 ± 3.3

29.8 ± 2.6

29.8 ± 3.4

30.9 ± 3.9

0.44

0.26

WC, cm

106.7 ± 8.1

105.2 ± 6.8

105.6 ± 8.6

109.4 ± 8.3

0.03

0.008

VAT, cm2

176.2 ± 61.2

166.3 ± 50.4

166.6 ± 59.8

196.4 ± 69.0

0.07

0.04

VAT proportion, %

34.3 ± 10.5

33.8 ± 10.7

33.5 ± 9.7

35.8 ± 11.2

0.59

0.44

DSAT, cm2

210.9 ± 70.0

204.3 ± 64.7

210.0 ± 78.4

218.6 ± 66.9

0.70

0.42

DSAT proportion, %

40.0 ± 6.1

39.8 ± 6.1

40.1 ± 5.8

39.4 ± 6.3

0.57

0.79

SSAT, cm2

134.9 ± 56.5

136.3 ± 55.6

130.0 ± 51.5

138.5 ± 63.2

0.79

0.87

SSAT proportion, %

25.6 ± 7.1

26.4 ± 7.3

25.7 ± 7.3

24.8 ± 6.9

0.63

0.33

IHFc, %

10.71 ± 10.6

8.3 ± 8.0

9.3 ± 9.8

14.5 ± 12.8

0.03

0.02

Fasting glucose, mg/dL

106.5 ± 16.2

100.8 ± 10.3

110.1 ± 18.9

108.4 ± 16.9

0.02

0.01

HOMA IRd

4.8 ± 3.5

3.9 ± 2.1

4.7 ± 3.5

5.9 ± 4.3

0.08

0.03

HbA1c, %

5.6 ± 0.5

5.5 ± 0.4

5.7 ± 0.5

5.6 ± 0.5

0.29

0.47

  1. Data are mean ± SD. aANOVA or Kruskal Wallis. bT-test or Mann–Whitney. cn = 119. dn = 114. Lowest tertile: men: ≤ − 0.44; women ≤ − 0.77; intermediate tertile: men: − 0.43 to 0.46, women: − 0.76 to 0.55; Highest tertile: men: 0.47+, women: 0.56+. Significant associations (p < 0.05) are represented in bold. Non-significant associations with p < 0.1 are represented in italics
  2. BMI body mass index, DSAT deep subcutaneous adipose tissue, HbA1c hemoglobin A1c, HOMA IR homeostatic model assessment of insulin resistance, IHF intrahepatic fat, SSAT superficial subcutaneous adipose tissue, VAT visceral adipose tissue, WC waist circumference